These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9301431)

  • 1. Dose-related effect of intravenous L-arginine on muscular blood flow of the calf in patients with peripheral vascular disease: a H215O positron emission tomography study.
    Schellong SM; Böger RH; Burchert W; Bode-Böger SM; Galland A; Frölich JC; Hundeshagen H; Alexander K
    Clin Sci (Lond); 1997 Aug; 93(2):159-65. PubMed ID: 9301431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 in peripheral vascular disease: a PET study of muscular blood flow.
    Schellong SM; Burchert W; Böger RM; Creutzig A; Hundeshagen H; Alexander K
    Scand J Clin Lab Invest; 1998 Apr; 58(2):109-17. PubMed ID: 9587162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels.
    Piatti P; Fragasso G; Monti LD; Setola E; Lucotti P; Fermo I; Paroni R; Galluccio E; Pozza G; Chierchia S; Margonato A
    Circulation; 2003 Jan; 107(3):429-36. PubMed ID: 12551867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-NAME, nitric oxide and jejunal motility, blood flow and oxygen uptake in dogs.
    Alemayehu A; Lock KR; Coatney RW; Chou CC
    Br J Pharmacol; 1994 Jan; 111(1):205-12. PubMed ID: 8012697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance.
    Baudouin SV; Bath P; Martin JF; Du Bois R; Evans TW
    Br J Clin Pharmacol; 1993 Jul; 36(1):45-9. PubMed ID: 8396955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic and biochemical responses to L-arginine and L-lysine infusions in normal subjects: L-arginine-induced vasodilatation cannot be explained by non-specific effects of cationic amino acids.
    Smulders RA; Aarsen M; Teerlink T; De Vries PM; Van Kamp GJ; Donker AJ; Stehouwer CD
    Clin Sci (Lond); 1997 Apr; 92(4):367-74. PubMed ID: 9176035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
    J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects.
    Bode-Böger SM; Böger RH; Creutzig A; Tsikas D; Gutzki FM; Alexander K; Frölich JC
    Clin Sci (Lond); 1994 Sep; 87(3):303-10. PubMed ID: 7955906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of L-arginine on insulin-mediated blood flow and glucose disposal in the elderly.
    Meneilly GS; Battistini B; Floras JS
    Metabolism; 2001 Feb; 50(2):194-9. PubMed ID: 11229429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of exogenous adenosine and voluntary exercise on human skeletal muscle perfusion and perfusion heterogeneity.
    Heinonen I; Kemppainen J; Kaskinoro K; Peltonen JE; Borra R; Lindroos MM; Oikonen V; Nuutila P; Knuuti J; Hellsten Y; Boushel R; Kalliokoski KK
    J Appl Physiol (1985); 2010 Feb; 108(2):378-86. PubMed ID: 19940098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.
    Bode-Böger SM; Böger RH; Galland A; Tsikas D; Frölich JC
    Br J Clin Pharmacol; 1998 Nov; 46(5):489-97. PubMed ID: 9833603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure.
    Kanaya Y; Nakamura M; Kobayashi N; Hiramori K
    Heart; 1999 May; 81(5):512-7. PubMed ID: 10212170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of N(G)-monomethyl-L-arginine into humans are dose dependent.
    Lepori M; Sartori C; Trueb L; Owlya R; Nicod P; Scherrer U
    J Hypertens; 1998 Apr; 16(4):519-23. PubMed ID: 9797197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus.
    Smulders RA; Stehouwer CD; Olthof CG; van Kamp GJ; Teerlink T; de Vries PM; Donker AJ
    Clin Sci (Lond); 1994 Jul; 87(1):37-43. PubMed ID: 8062517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans.
    Higashi Y; Oshima T; Ono N; Hiraga H; Yoshimura M; Watanabe M; Matsuura H; Kambe M; Kajiyama G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2198-202. PubMed ID: 7608279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of NG-nitro-L-arginine methyl ester upon basal blood flow and endothelium-dependent vasodilatation in the dog hindlimb.
    White DG; Drew GM; Gurden JM; Penny DM; Roach AG; Watts IS
    Br J Pharmacol; 1993 Mar; 108(3):763-8. PubMed ID: 8467362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N(G)-monomethyl-L-arginine alters insulin-mediated calf blood flow but not glucose disposal in the elderly.
    Meneilly GS; Elliott T; Battistini B; Floras JS
    Metabolism; 2001 Mar; 50(3):306-10. PubMed ID: 11230783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-arginine improves post-ischemic vasodilation in coronary heart disease patients taking vasodilating drugs.
    Iannuzzi A; Iannuzzo G; Sapio C; Pauciullo P; Iorio D; Spampinato N; Mancini M; Rubba P
    J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):121-7. PubMed ID: 11509918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X.
    Bøttcher M; Botker HE; Sonne H; Nielsen TT; Czernin J
    Circulation; 1999 Apr; 99(14):1795-801. PubMed ID: 10199874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertension.
    Böger RH; Mügge A; Bode-Böger SM; Heinzel D; Höper MM; Frölich JC
    Int J Clin Pharmacol Ther; 1996 Aug; 34(8):323-8. PubMed ID: 8864793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.